[{"NetIncomeLoss_2_Q2_USD":18303000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AccruedRoyaltiesCurrent_0_Q2_USD":5918000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q2_USD":50000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":1035000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":103000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-34110000.0,"Depreciation_2_Q2_USD":688000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":47000.0,"IncomeTaxReconciliationOtherReconcilingItems_2_Q2_USD":100000.0,"IncomeTaxReconciliationOtherReconcilingItems_1_Q2_USD":300000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_Q2_USD":-135000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_1_Q2_USD":-136000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":31788000.0,"AssetsCurrent_0_Q2_USD":446652000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":2117000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-666000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":197352000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":58144000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":28347000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2174917.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":2212724.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":289000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":163670000.0,"CommonStockSharesIssued_0_Q2_shares":55627666.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":20000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":339251000.0,"Liabilities_0_Q2_USD":86425000.0,"Assets_0_Q2_USD":567645000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":660086000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":57242000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q2_USD":6566000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":36379000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":20248000.0,"EarningsPerShareBasic_2_Q2_USD":0.33,"EarningsPerShareBasic_1_Q2_USD":0.17,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-29000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":56705419.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":56903340.0,"AssetsFairValueDisclosure_0_Q2_USD":348249000.0,"AccountsReceivableNetCurrent_0_Q2_USD":37090000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":4729000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":2951000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-1016000.0,"CommonStockValue_0_Q2_USD":56000.0,"Revenues_2_Q2_USD":130568000.0,"Revenues_1_Q2_USD":67899000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":888000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":2138000.0,"CostsAndExpenses_2_Q2_USD":107858000.0,"CostsAndExpenses_1_Q2_USD":55530000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1366000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":12000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":18167000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":9564000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":739000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":369000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0075,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10740000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-136000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-89000.0,"ShareBasedCompensation_2_Q2_USD":7649000.0,"OtherIncome_1_Q2_USD":235000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":339181000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-179025000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-3791000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":7064000.0,"CommonStockSharesOutstanding_0_Q2_shares":55627666.0,"EarningsPerShareDiluted_2_Q2_USD":0.32,"EarningsPerShareDiluted_1_Q2_USD":0.17,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":117000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3740000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":28210000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":55365558.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":55582916.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2_Q2_pure":0.46,"LiabilitiesCurrent_0_Q2_USD":71989000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":57822000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":12014000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2138000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":1339861.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":1320424.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q2_USD":53000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":20820000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"InventoryNoncurrent_0_Q2_USD":6587000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3631000.0,"NetIncomeLoss_1_Q2_USD":9653000.0,"OtherIncome_2_Q2_USD":322000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":428000.0,"StockholdersEquity_0_Q2_USD":481220000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":3696000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":9898000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q2_USD":78641000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":8.91,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1554000.0,"OtherComprehensiveIncomeLossTax_2_Q2_USD":-30000.0,"OtherComprehensiveIncomeLossTax_1_Q2_USD":-31000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":130568000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":67899000.0,"OperatingIncomeLoss_2_Q2_USD":22710000.0,"OperatingIncomeLoss_1_Q2_USD":12369000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_2_Q2_USD":12596000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":23032000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2_Q2_USD":-31000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q2_USD":16000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":339251000.0,"InventoryNet_0_Q2_USD":1055000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"PreferredStockValue_0_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":2906000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":567645000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4008000.0,"PreferredStockSharesAuthorized_0_Q2_shares":20000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7649000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3740000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2142000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":12604000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":6932000.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210729"}]